Board of Directors 2020 - 2022

The Board of Directors establishes vision, mission and values; provides proper financial oversight, including approving annual budget; and reviews the performance of the HKAPI Executive Office.

 

PRESIDENT

Dr. Daniel Thurley

General Manager

Roche Hong Kong Limited

Vice President

Ms. Dorine Leung

General Manager & Country Vice President

Novartis Pharmaceuticals (HK) Ltd
 

Board Members

Mr. Richard Sun

General Manager, Hong Kong, Malaysia & Singapore

AbbVie Ltd

Ms. Kara Cheung

General Manager

Amgen HK Ltd

Mr. Gwenael Meneux

General Manager, Hong Kong & Macau

AstraZeneca Hong Kong Ltd

Mr. Lawrence Wong

General Manager

Ferring Pharmaceuticals Ltd

Ms. Peggy Fung

General Manager, Pharmaceuticals - HK and Macau

GlaxoSmithKline Ltd

Mr. Alex Ho

General Manager

Janssen, a Division of Johnson & Johnson (HK) Ltd

Mr. Fong Wai-ting

Vice President, Healthcare

Medinova AG (a member of DKSH)

Honorary Legal Advisors

Dr. Isabella Liu

Partner

Baker & McKenzie

Mr. Marcus Pollard

Counsel

Linklaters

Mr. Henry Wheare